Physician profile
Patricia Torres
NPI 1366007031
$3,450.58
in general payments reported to CMS, 2019-2025
14 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,278 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,977 · Travel and Lodging: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,976.66 |
| Travel and Lodging | $1,473.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,663.66 | 2024 | Ovitex 2s |
| Davol INC. | $355.92 | 2025 | Arista, Phasix Mesh |
| Dilon Technologies, INC. | $326.39 | 2024 | Hemoblast Bellows |
| Integra Lifesciences Corporation | $239.89 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| W. L. Gore & Associates, INC. | $215.65 | 2024-2025 | Gore Enform Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Urgo Medical North America, LLC | $161.14 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Becton, Dickinson and Company | $148.79 | 2024 | Phasix Mesh |
| Acera Surgical, INC. | $134.40 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $110.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $23.59 | 2025 | Abthera, V.A.C. Veraflo |
| Convatec INC. | $19.29 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $17.77 | 2025 | |
| Smith+Nephew, INC. | $16.94 | 2025 | Pico 7 |
| Vertex Pharmaceuticals Incorporated | $16.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.